Wordt geladen...
Targeting HER (ERBB) Signaling in Head and Neck Cancer: An Essential Update
HNC (head and neck cancer) remains the 6(th) most common carcinoma worldwide. The suboptimal survival and toxicities observed with conventional approaches warrant exploration of novel therapeutic strategies such as targeted therapies. Although targeting EGFR (epidermal growth factor receptor) with c...
Bewaard in:
| Gepubliceerd in: | Mol Aspects Med |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8028037/ https://ncbi.nlm.nih.gov/pubmed/26163475 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mam.2015.07.001 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|